| Integrated metabolic and epigenomic reprograming by H3K27M mutations in diffuse intrinsic pontine gliomas C Chung, SR Sweha, D Pratt, B Tamrazi, P Panwalkar, A Banda, J Bayliss, ... Cancer Cell 38 (3), 334-349. e9, 2020 | 140 | 2020 |
| Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways Venneti S*, Kawabiki AR*, Ji S*, Waszak S*, Sweha SR*,...,Koschmann C Cancer Discovery, 2023 | 81 | 2023 |
| Molecular biomarkers predictive of sertraline treatment response in young children with fragile X syndrome RR AlOlaby*, SR Sweha*, M Silva, B Durbin-Johnson, CM Yrigollen, ... Brain and Development 39 (6), 483-492, 2017 | 38 | 2017 |
| Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas P Panwalkar*, B Tamrazi*, D Dang*, C Chung*, S Sweha*, SK Natarajan*, ... Science translational medicine 13 (614), eabc0497, 2021 | 37 | 2021 |
| Distribution of AGG interruption patterns within nine world populations CM Yrigollen, S Sweha, B Durbin-Johnson, L Zhou, E Berry-Kravis, ... Intractable & rare diseases research 3 (4), 153-161, 2014 | 29 | 2014 |
| Epigenetically defined therapeutic targeting in H3.3G34R/V high-grade gliomas SR Sweha, C Chung, SK Natarajan, P Panwalkar, M Pun, A Ghali, ... Science translational medicine 13 (615), eabf7860, 2021 | 23 | 2021 |
| Clinical and molecular correlates in fragile X premutation females P Jiraanont*, SR Sweha*, RR AlOlaby, M Silva, HT Tang, ... Eneurologicalsci 7, 49-56, 2017 | 14 | 2017 |
| Targeting SWI/SNF ATPases in H3. 3K27M diffuse intrinsic pontine gliomas M Mota, SR Sweha, M Pun, SK Natarajan, Y Ding, C Chung, D Hawes, ... Proceedings of the National Academy of Sciences 120 (18), e2221175120, 2023 | 11 | 2023 |
| Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma D Messinger, MK Harris, JR Cummings, C Thomas, T Yang, SR Sweha, ... Neuro-Oncology, 2022 | 10 | 2022 |
| Therapeutic targeting of differentiation state-dependent metabolic vulnerabilities in DIPG NE Mbah, AL Myers, C Chung, JK Thompson, HS Hong, P Sajjakulnukit, ... bioRxiv, 2022 | 6 | 2022 |
| ZFTA-RELA fusion aberrantly drives glutamine metabolism in lethal pediatric ependymomas SK Natarajan, J Haggerty-Skeans, J Lum, P Narayanan, S Sweha, S Sunil, ... Cancer Research 83 (7_Supplement), 6047-6047, 2023 | | 2023 |
| Epigenomic Reprogramming and Therapeutics Development in High-Grade Gliomas SR Sweha | | 2021 |
